Vaccines for Pediatric Infectious Diseases

Dear Colleagues,

Vaccination is one of the most effective public health interventions, particularly in the field of pediatric infectious diseases. The development of new vaccines, along with growing real-world evidence of their effectiveness, continues to impact global immunization programs. In recent years, pediatric vaccinology has expanded beyond traditional targets, introducing novel disease prevention strategies that address significant health burdens in childhood.

We invite you to contribute to our Special Issue, "Vaccines for Pediatric Infectious Diseases." The goal of this series is to publish high-quality reviews and original research papers that showcase recent scientific and clinical developments in pediatric vaccinology. We aim to enhance our understanding of how both new and established vaccines can effectively prevent infectious diseases in children and explore how these advancements can inform public health actions.

This Special Issue focuses on the pediatric setting; we hope to integrate existing evidence, acknowledge unmet needs, and guide future research and policy. This Special Issue will spotlight recent advancements in children's vaccines, provide critical summaries of new information, and discuss the

potential benefits and risks associated with introducing new vaccines into pediatric vaccination schedules worldwide. We welcome original research articles and reviews, including:

• Innovations in RSV vaccines for children and infants;
• Developments in meningococcal vaccines;
• Real-world acceptability and performance of PCV20 in pediatric populations;
• Developments and needs for Group A Streptococcus vaccines to prevent invasive disease and pharyngitis;
• Immunization strategies for pregnant women to prevent respiratory and systemic infections in infants;
• Progress in norovirus vaccines for children;
• Next-generation pertussis vaccines.

We look forward to receiving your contributions.

Prof. Dr. Artur Sulik
Dr. Kacper Toczylowski
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• pediatric vaccines
• RSV
• meningococcal vaccines
• pneumococcal vaccines
• COVID-19
• maternal immunization
• Group A streptococcus
• vaccine effectiveness